Acronym:
Stafford
ACTRN/NCT /ethics:
Scientific title:
Summary of trial and patient characteristics
| Cancer Type | Other | ||
|---|---|---|---|
| Trial Type | Early detection, diagnosis, prognosis | ||
| Phase | All phases | Tumour Stream | Rare cancers |
| Age Range | 18 years and older | Cancer Stage | All stages |
| Sex | Both | Anticipated Start Date | |
| Molecular Target | Anticipated End Date | ||
| Cancer Type | Other |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | All phases |
| Age Range | 18 years and older |
| Sex | Both |
| Molecular Target | |
| Tumour Stream | Rare cancers |
| Cancer Stage | All stages |
| Anticipated Start Date | |
| Anticipated End Date |
Trial Summary
WEHI Stafford Fox Rare Cancer program: Discovery of novel therapeutic targets within rare cancers.
Lay Summary
Sponsor / Cooperative group
Participating Hospitals
| Hospital | Clinical Trial Coordinator | Phone | Principal Investigator | Recruitment Status | |
|---|---|---|---|---|---|
| Royal Adelaide Hospital | Anne Milton | anne.milton@sa.gov.au | 08 7074 2342 | Professor Michael Brown | Recruitment on Hold |